HDAC3 and acute myeloid leukemia: Moreover, pharmacological inhibition of HDAC3 in HS-5 cells using the BG45 reversed AML cells’ CM-induced mRNAs expression of inflammatory cytokines (Fig. 2I and Fig. S2E, F).